. . . . . "patients" . . . "Carvedilol" . . . "thiazide" . . . "myocardial infarction" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "2022-10-11T07:14:02.124516"^^ . . " Carvedilol is indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of ≤40%. It can be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. It is indicated for the management of essential. essential. heart failure." . "2.3.0" . "RSA" . "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB" . "U/r65UOfFROfafNoL599E6jgtio6BnZAIOQ1yWdFWz31jXT3rO1XdUkfRnFBq0DJBvvLCK6Kgx3dPyzLSxzt4c9/yLUpeWGwA2P6nHElBdOI3E2TPwHNUPGoPM7kjPyL2Jvb6GbpBIpfxJ1oDg7V3VISyL+TYzo8C4zyPsuOawgFdwpv5GRmVcxQikIyseagaWl8jyXG8m67wo16NoNUUoT4UACC70paz+bzcSlgcVxCe4y5TL+nXAzUCM9T8KvBMe714vlQ8/duaRBOhT2Qy0N6qB5gdFeDOWCqvH3VFUtSqqaEQSrrIFvOCO3Ydiuu8DRsmg69hVheB/qGTG5vUA==" . . "2022-10-11T07:14:02.124516"^^ . .